Clinical research

SYNERGY-NASH: Tirzepatide in MASH with fibrosis

null. Sample size not extracted, over an unspecified duration. Sponsor: not stated.

SYNERGY-NASH (no registry ID on file) tested against a comparator in . Unverified — no source on file: the source is a citable record we could not authoritatively link, which we have not independently re-extracted from the full paper in this session.

Study design

Results

Not extracted.

Adverse events & discontinuations

Not extracted from the source in this session.

Limitations

Not assessed.

Practical interpretation

This is one trial, reported by its sponsor, read directly against the registry and publication linked below — GLP Ranked has not re-run the statistics or obtained the patient-level data. Results describe group averages under trial conditions and may not describe any individual's outcome, including with a compounded, non-FDA-approved version of a similar active ingredient. Always check the primary source before citing a specific number.